Loading data
PHRNYSE
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 467.82 m USD | 410.48 m USD | 345.99 m USD | 280.91 m USD | 213.23 m USD |
| Research and development expense | 121.48 m USD | 117.36 m USD | 112.35 m USD | 91.24 m USD | 52.27 m USD |
| Operating profit | -6.61 m USD | -58.1 m USD | -136.48 m USD | -176.55 m USD | -116.82 m USD |
| Interest expense | — | — | 1.85 m USD | 1.41 m USD | 1.16 m USD |
| Profit before tax | -8.94 m USD | -55.81 m USD | -135.34 m USD | -175.66 m USD | -117.98 m USD |
| Income tax expense | -11.25 m USD | 2.72 m USD | 1.54 m USD | 483 k USD | 182 k USD |
| Net income (reported basis) | 2.31 m USD | -58.53 m USD | -136.89 m USD | -176.15 m USD | -118.16 m USD |
| Basic earnings per share | 0.04 USD/share | -1.02 USD/share | -2.51 USD/share | -3.36 USD/share | -2.37 USD/share |
| Diluted earnings per share | 0.04 USD/share | -1.02 USD/share | -2.51 USD/share | -3.36 USD/share | -2.37 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.